Williams D, Thompson D G, Heggie L, O'Hanrahan T, Bancewicz J
Department of Medicine, Hope Hospital, Salford, England.
Gastroenterology. 1994 Jan;106(1):108-16. doi: 10.1016/s0016-5085(94)94713-9.
BACKGROUND/AIMS: To investigate whether healing of the esophagitis was associated with an improvement in esophageal clearance function, 15 patients with endoscopic and histologically confirmed erosive esophagitis were studied both before and after 1-month treatment with 40 mg/day of omeprazole.
All patients were studied before and after treatment by perfusion manometry to measure esophageal pressures, and a traction measuring device was used to record aboral forces generated by graded intraluminal distension.
Before treatment, standard manometry showed reduced lower esophageal sphincter pressures (4 mm Hg [range, 2-9] vs. a control of 12 mm Hg [range, 5-25]; P < 0.01) and distal peristaltic amplitudes (29 mm Hg [range, 5-57] vs. a control of 55 mg Hg [range, 32-90]; P < 0.01). Responses to distension were also abnormal with a higher threshold for induction of contractile activity (12 mL [range, 8.5-14] vs. control values of 5 mL [range, 3-10]; P < 0.01) and weaker clearance forces (5 g [range, 0-80] vs. control values of 20 g [range, 8-90]; P < 0.01). After treatment, all patients showed endoscopic and histological evidence of healing, but not consistent improvement in either lower esophageal sphincter pressure (5 mm Hg [range, 3-7]; P > 0.05 vs. pretreatment) or peristaltic amplitude (35 mm Hg [range, 10-55]) was found. However, responses to distension did improve, with a decrease in distension threshold to 10 mL (range, 7-14; P = 0.04) and enhancement of traction force to 14 g (range, 0-95; P < 0.01). Patients with the worst pretreatment distension responses showed the least improvement with therapy.
Improvement in esophageal clearance can be achieved by the healing of esophagitis, although the capacity for functional benefit appears to be related to the degree of dysfunction present before therapy.
背景/目的:为研究食管炎的愈合是否与食管清除功能的改善相关,对15例经内镜和组织学确诊的糜烂性食管炎患者在接受每日40毫克奥美拉唑治疗1个月前后进行了研究。
所有患者在治疗前后均通过灌注测压法测量食管压力,并使用牵引测量装置记录分级腔内扩张产生的向肛侧力。
治疗前,标准测压显示食管下括约肌压力降低(4毫米汞柱[范围2 - 9],对照组为12毫米汞柱[范围5 - 25];P < 0.01)以及远端蠕动幅度降低(29毫米汞柱[范围5 - 57],对照组为55毫米汞柱[范围32 - 90];P < 0.01)。对扩张的反应也异常,收缩活动诱导阈值较高(12毫升[范围8.5 - 14],对照组为5毫升[范围3 - 10];P < 0.01)且清除力较弱(5克[范围0 - 80],对照组为20克[范围8 - 90];P < 0.01)。治疗后,所有患者均显示出内镜和组织学愈合证据,但食管下括约肌压力(5毫米汞柱[范围3 - 7];与治疗前相比P > 0.05)或蠕动幅度(35毫米汞柱[范围10 - 55])均未出现一致改善。然而,对扩张的反应确实有所改善,扩张阈值降至10毫升(范围7 - 14;P = 0.04)且牵引力增强至14克(范围0 - 95;P < 0.01)。治疗前对扩张反应最差的患者治疗后改善最少。
食管炎的愈合可实现食管清除功能的改善,尽管功能获益能力似乎与治疗前存在的功能障碍程度有关。